Literature DB >> 12615441

Modulation of dendritic cell endocytosis and antigen processing pathways by Escherichia coli heat-labile enterotoxin and mutant derivatives.

Liljana Petrovska1, Luciene Lopes, Cameron P Simmons, Mariagrazia Pizza, Gordon Dougan, Benjamin M Chain.   

Abstract

Escherichia coli heat-labile enterotoxin (LT) is known to be a potent adjuvant of both the mucosal and systemic immune systems but the mechanism of action leading to adjuvant activity remains incompletely understood. This study investigates the action of LT and LT mutants with impaired enzymatic activity, on the function of dendritic cells. Wild-type LT and LTR72, which retains some ADP ribosyltransferase activity, induced a selective increase in cell surface expression of B7.1, and a selective decrease of CD40 expression on mouse bone marrow derived dendritic cells. LTK63 and LT-B had no obvious effect on the expression of these antigens on similar dendritic cells. LT-treated dendritic cells also showed a profoundly impaired ability to present protein antigen (ovalbumin) to cognate T cells, although this effect was not observed with non-toxic LT mutants. LT and LTR72-treated cells showed a slower rate of receptor-mediated endocytosis as measured by flow cytometric analysis of uptake of fluorescently labelled dextran. Furthermore, confocal microscopy showed changes in the intracellular distribution of endocytosed molecules, and of the class II containing acidic antigen processing compartments. This response of dendritic cells to toxin is likely to play an important role in determining the adjuvant activity of these molecules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615441     DOI: 10.1016/s0264-410x(02)00696-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.

Authors:  Audrey Glynn; Chad J Roy; Bradford S Powell; Jeffrey J Adamovicz; Lucy C Freytag; John D Clements
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  The interaction between staphylococcal superantigen-like proteins and human dendritic cells.

Authors:  A M Al-Shangiti; S P Nair; B M Chain
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

Review 3.  Heat-labile enterotoxins as adjuvants or anti-inflammatory agents.

Authors:  Shuang Liang; George Hajishengallis
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

4.  Probing local innate immune responses after mucosal immunisation.

Authors:  Lindsay J Hall; Simon Clare; Gordon Dougan
Journal:  J Immune Based Ther Vaccines       Date:  2010-09-13

5.  Mutual enhancement of virulence by enterotoxigenic and enteropathogenic Escherichia coli.

Authors:  John K Crane; Shilpa S Choudhari; Tonniele M Naeher; Michael E Duffey
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

6.  The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens.

Authors:  Elizabeth B Norton; Louise B Lawson; Zaid Mahdi; Lucy C Freytag; John D Clements
Journal:  Infect Immun       Date:  2012-04-23       Impact factor: 3.441

7.  Escherichia coli heat-labile detoxified enterotoxin modulates dendritic cell function and attenuates allergic airway inflammation.

Authors:  I-Ping Lin; Yu-Shen Hsu; Ssu-Wei Kang; Miao-His Hsieh; Jiu-Yao Wang
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

8.  Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D.

Authors:  Luciana A F Gil; Carlos Eduardo P da Cunha; Gustavo M S G Moreira; Felipe M Salvarani; Ronnie A Assis; Francisco Carlos F Lobato; Marcelo Mendonça; Odir A Dellagostin; Fabricio R Conceição
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

9.  Parenteral Adjuvant Effects of an Enterotoxigenic Escherichia coli Natural Heat-Labile Toxin Variant.

Authors:  Catarina J M Braga; Juliana F Rodrigues; Yordanka Medina-Armenteros; Luís E Farinha-Arcieri; Armando M Ventura; Silvia B Boscardin; Maria E Sbrogio-Almeida; Luís C S Ferreira
Journal:  Front Immunol       Date:  2014-01-07       Impact factor: 7.561

10.  Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination.

Authors:  C R Cabauatan; R Campana; K Niespodziana; C Reinisch; U Lundberg; A Meinke; R Henning; A Neubauer; R Valenta
Journal:  Allergy       Date:  2016-09-30       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.